Cyclopentanol, 5-[2-[[(4-methoxyphenyl)diphenylmethyl]amino]-6-(phenylmethoxy)-9H-purin-9-yl]-3-(phenylmethoxy)-2-[(phenylmethoxy)methyl]-, (1S,2S,3S,5S)-(CAS: 142217-78-5)
![Cyclopentanol, 5-[2-[[(4-methoxyphenyl)diphenylmethyl]amino]-6-(phenylmethoxy)-9H-purin-9-yl]-3-(phenylmethoxy)-2-[(phenylmethoxy)methyl]-, (1S,2S,3S,5S)- Cyclopentanol, 5-[2-[[(4-methoxyphenyl)diphenylmethyl]amino]-6-(phenylmethoxy)-9H-purin-9-yl]-3-(phenylmethoxy)-2-[(phenylmethoxy)methyl]-, (1S,2S,3S,5S)-](https://cnstatic.chemtradehub.com/structs/142/142217-78-5-5967.webp)
CAS号
相关产品
其他供应商提供的 Cyclopentanol, 5-[2-[[(4-methoxyphenyl)diphenylmethyl]amino]-6-(phenylmethoxy)-9H-purin-9-yl]-3-(phenylmethoxy)-2-[(phenylmethoxy)methyl]-, (1S,2S,3S,5S)-
基本信息
分子式
C52H49N5O5
分子量
824 g/mol
Physical Properties
密度
1.23
化学标识符
SMILES
COC1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=CC=C3)NC4=NC5=C(C(=N4)OCC6=CC=CC=C6)N=CN5C7CC(C(C7O)COCC8=CC=CC=C8)OCC9=CC=CC=C9
InChIKey
ZLWZEFPIJWNPCO-ABKHIKNWSA-N
数据库引用
MDL号
MFCD09750978
常见问题
恩替卡韦中间体N5(CAS号:142217-78-5)在合成和使用过程中需符合多个国家和地区的法规要求,如GHS(全球统一制度)分类标准,REACH法规(欧盟化学品注册、评估、授权和限制法规),以及美国FDA和EPA的相关规定。这些法规旨在确保化学品的安全使用和环境保护。
在合成过程中,恩替卡韦中间体N5(CAS号:142217-78-5)的替代品通常包括其他具有相似结构和功能的类似物或异构体,如含有不同取代基的衍生物。但这些替代品的合成路线和生产过程可能有所不同,需根据具体情况选择合适的替代方案。
恩替卡韦中间体N5(CAS号:142217-78-5)作为恩替卡韦的重要中间体,其市场需求主要集中在药物合成领域。随着药物研发的不断推进和新药上市的增加,恩替卡韦及其中间体的需求将持续增长。此外,环保和可持续发展的需求也促使研究者探索更加绿色的合成方法。
处理含有恩替卡韦中间体N5(CAS号:142217-78-5)的废料时,首先应收集并分类,然后根据其性质选择合适的处理方法。通常,废料可以通过化学方法进行水解或氧化,使其转化为无害物质。对于无法通过化学方法处理的废料,可以考虑焚烧或采用专业的废物处理服务。处理过程中需严格遵守当地环保法规,确保不会对环境造成污染。
安全须知
使用前请验证产品规格和安全数据。联系供应商获取详细安全信息。
请始终遵循正确的操作程序


![(1S,2R)-2-[(Benzyloxy)methyl]-3-cyclopenten-1-ol](https://cnstatic.chemtradehub.com/structs/110/110567-21-0-f177.webp)
![Ethyl (4as,9br)-6-bromo-1h,2h,3h,4h,4ah,5h,9bh-pyrido[4,3-b]indole-2-carboxylate](https://cnstatic.chemtradehub.com/structs/105/1059630-08-8-c7a7.webp)
![N-[(9H-Fluoren-9-ylmethoxy)carbonyl]glycine](https://cnstatic.chemtradehub.com/structs/290/29022-11-5-1c3b.webp)
![Methyl 2-((2R,4aS,6S,7R,8S,8aS)-7,8-bis((tert-butyldimethylsilyl)oxy)-6-((S,E)-1-((tert-butyldimethylsilyl)oxy)-3-(trimethylsilyl)allyl)octahydropyrano[3,2-b]pyran-2-yl)acetate](https://cnstatic.chemtradehub.com/structs/185/185411-11-4-cced.webp)
![2-Methyl-2-propanyl [(1R,2S,5S)-2-amino-5-(dimethylcarbamoyl)cyclohexyl]carbamate ethanedioate (1:1)](https://cnstatic.chemtradehub.com/structs/121/1210348-34-7-6481.webp)

![(2S)-2-{[(9H-Fluoren-9-ylmethoxy)carbonyl]amino}-4-[(2-methyl-2-propanyl)oxy]-4-oxobutanoic acid](https://cnstatic.chemtradehub.com/structs/719/71989-14-5-7c0a.webp)
![methyl 4-[(1R,2S,3aR,8bR)-2-hydroxy-1-(hydroxymethyl)-2,3,3a,8b-tetrahydro-1H-cyclopenta[b][1]benzofuran-5-yl]butanoate](https://cnstatic.chemtradehub.com/structs/882/88277-19-4-c9fe.webp)
![Cyclopentanol, 5-[2-[[(4-methoxyphenyl)diphenylmethyl]amino]-6-(phenylmethoxy)-9H-purin-9-yl]-3-(phenylmethoxy)-2-[(phenylmethoxy)methyl]-, (1S,2S,3S,5S)- — 金锦乐(湖南)化学有限公司](https://cnstatic.chemtradehub.com/suppliers/67ce76192b2de6e8e95a464e/67ce76192b2de6e8e95a464e-logo.webp)
![Cyclopentanol, 5-[2-[[(4-methoxyphenyl)diphenylmethyl]amino]-6-(phenylmethoxy)-9H-purin-9-yl]-3-(phenylmethoxy)-2-[(phenylmethoxy)methyl]-, (1S,2S,3S,5S)- — 武汉本杰明医药股份有限公司](https://cnstatic.chemtradehub.com/suppliers/67ce018057537e5c8069b11d/67ce018057537e5c8069b11d-logo.webp)
![Cyclopentanol, 5-[2-[[(4-methoxyphenyl)diphenylmethyl]amino]-6-(phenylmethoxy)-9H-purin-9-yl]-3-(phenylmethoxy)-2-[(phenylmethoxy)methyl]-, (1S,2S,3S,5S)- — 赫澎(上海)生物科技有限公司](https://cnstatic.chemtradehub.com/suppliers/67ceccf22b2de6e8e95a5e0f/67ceccf22b2de6e8e95a5e0f-logo.webp)
![Cyclopentanol, 5-[2-[[(4-methoxyphenyl)diphenylmethyl]amino]-6-(phenylmethoxy)-9H-purin-9-yl]-3-(phenylmethoxy)-2-[(phenylmethoxy)methyl]-, (1S,2S,3S,5S)- — 湖北诺纳科技有限公司](https://cnstatic.chemtradehub.com/suppliers/67ce946e2b2de6e8e95a4840/67ce946e2b2de6e8e95a4840-logo.webp)